• Home
  • NEW DAY MEDICINE
  • 4 (66) 2024
  • 129 -4 (66) 2024 - Aghababyan I.R., Sadikova Sh.Sh. - STUDYING THE COMPONENT COMPOSITION OF THE BODY AT THE EARLY STAGE OF NON-ALCOHOLIC FATTY LIVER DISEASE

129 -4 (66) 2024 - Aghababyan I.R., Sadikova Sh.Sh. - STUDYING THE COMPONENT COMPOSITION OF THE BODY AT THE EARLY STAGE OF NON-ALCOHOLIC FATTY LIVER DISEASE

STUDYING THE COMPONENT COMPOSITION OF THE BODY AT THE EARLY STAGE OF NON-ALCOHOLIC FATTY LIVER DISEASE

Aghababyan I.R. Samarkand State Medical University Uzbekistan

Sadikova Sh.Sh. Samarkand State Medical University Uzbekistan

Resume

In the last decade, the steady growth of non-alcoholic fatty liver disease (NAFLD) has been actively discussed in domestic and foreign literature. In the Russian Federation, the detection rate of NAFLD increased from 27.0% in 2007 to 37.1% in 2014 and ranked first among liver diseases [1,2,3,4]. There are several clinical and morphological forms of NAFLD: from steatosis, reversible with timely treatment, to steatohepatitis, fibrosis, with progression passing into liver cirrhosis and / or hepatocellular carcinoma. In early clinical diagnosis, and therefore timely treatment, the asymptomatic course of the early stage of NAFLD – liver steatosis causes great difficulties [5,6].

Keywords: component composition of the body, total fat, visceral fat, pathogenesis of non-alcoholic fatty liver disease

First page

719

Last page

724

For citation: Aghababyan I.R., Sadikova Sh.Sh. - STUDYING THE COMPONENT COMPOSITION OF THE BODY AT THE EARLY STAGE OF NON-ALCOHOLIC FATTY LIVER DISEASE//New Day in Medicine 4(66)2024 719-724 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Агабабян, И. Р., Искандарова, Ф. И., Мухтаров, С. Н. (2019). Роль маркеров воспаления жировой ткани как основной фактор в развитии артериальной гипертензии у больных метаболическим синдромом. //In The priorities of the world science: experiments and scientific debate (pp. 25-30)..( in rus)
  2. Агабабян, И. Р., Исмаилов, Ж. А., & Рузиева, А. А. (2020). Хроническая сердечная недостаточность у молодых пациентов с ожирением на фоне хронической обструктивной болезни легких. //Достижения науки и образования, (3 (57)), 84-87..( in rus)
  3. Ivashkin, V. T., Drapkina, O. M., Mayev, I. V., Trukhmanov, A. S., Blinov, D. V., Palgova, L. K., ... Ushakova, T. I. (2015). Prevalence of non-alcoholic fatty liver disease in patients of outpatient practice in the Russian Federation: results of the DIREG 2 study. //Russian Journal of Gastroenterology, Hepatology, Coloproctology, 25(6), 31-41. (in rus)
  4. Kim, D., & Kim, W. R. (2017). Nonobese fatty liver disease. //Clinical gastroenterology and hepatology, 15(4), 474-485.
  5. Madeira, F. B., Silva, A. A., Veloso, H. F., Goldani, M. Z., Kac, G., Cardoso, V. C., ... & Barbieri, M. A. (2013). Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. //PloS one, 8(3), e60673.
  6. Mayevskaya, M. V., Nadinskaia, M. Y., Lunkov, V. D., Pirogova, I. Y., Chesnokov, E. V., Kodzoeva, K. B., Ivashkin, V. T. (2020). An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study. //Russian Journal of Gastroenterology, Hepatology, Coloproctology, 29(6), 22-29.
  7. Oliveros E., Somers V.K., Sochor O., Goel K., Lopez-Jimenez F. The concept of normal weight obesity // Progress in Cardiovascular Diseases. – 2014. – Vol. 56 (4). – P. 426-33. doi: 10.1016/j.pcad.2013.10.003.
  8. Podobenova, D. V., Samoilova, Yu. G., Oleinik, O. A., & Kobyakova, O. S. (2019). The role of bioimpedance measurement in the diagnosis of visceral obesity in children and adolescents. Medicine: Theory and Practice, 4(S), 426-426.Gepner, Y., Shelef, I., Komy, O., Cohen, N., Schwarzfuchs, D., Bril, N., ... Shai, I. (2019). The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. //Journal of hepatology, 71(2), 379-388. ( in rus)
  9. Rinella, M. E. (2015). Nonalcoholic fatty liver disease: a systematic review. //Jama, 313(22), 2263-2273.
  10. Vakhrushev, Ya. M., Suchkova, E. V., & Lukashevich, A. P. (2020). Evaluation of the effectiveness of differentiated therapy of non-alcoholic fatty liver disease. //Therapeutic Archive, 92(2), 29-33.

    file

    download